πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· INN Directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed
4,797
Companies
1,769
Pipeline programs
20,548

Quick answer

NovaPharmaNews tracks 4,797 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

Showing page 58 of 200 Β· A–Z by INN

  1. dodecafluoropentane

    ECHOGEN

    EMA: withdrawn

    V08DA
  2. dofetilide

    TIKOSYN Teva Pharma GmbH

    ORAL FDA: approved Β· EMA: withdrawn

    C01BD04
  3. dolasetron mesylate

    ANZEMET

    INJECTION FDA: approved

  4. dolutegravir

    TIVICAY ViiV Healthcare Pty Ltd

    ORAL FDA: approved Β· EMA: approved Β· TGA: approved

    J05AR
  5. dolutegravir + abacavir + lamivudine

    TRIUMEQ ViiV Healthcare Pty Ltd

    TGA: approved

  6. dolutegravir + lamivudine

    DOVATO ViiV Healthcare Pty Ltd

    TGA: approved

  7. dolutegravir + rilpivirine

    JULUCA ViiV Healthcare Pty Ltd

    TGA: approved

  8. dolutegravir and lamivudine

    DOLUTEGRAVIR AND LAMIVUDINE

    FDA: approved

  9. dolutegravir lamivudine tenofovir alafenamide

    DOLUTEGRAVIR LAMIVUDINE TENOFOVIR ALAFENAMIDE

    FDA: approved

  10. dolutegravir sodium

    TIVICAY

    ORAL FDA: approved Β· PMDA: approved

  11. dolutegravir, emtricitabine and tenofovir alafenamide

    DOLUTEGRAVIR, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE

    ORAL FDA: approved

  12. domperidone

    APO-DOMPERIDONE Apotex Pty Ltd

    TGA: approved

  13. donanemab

    KISUNLA

    EMA: approved Β· PMDA: approved

    N06DX05
  14. donanemab-azbt

    KISUNLA

    INJECTION FDA: approved

  15. donepezil

    ARICEPT Pfizer Australia Pty Ltd

    TGA: approved

  16. donepezil hydrochloride

    ADLARITY Amneal Pharma Europe Ltd

    TRANSDERMAL FDA: approved Β· NMPA: clinical trials

  17. donidalorsen

    DAWNZERA

    EMA: approved

    B06AC
  18. donidalorsen sodium

    DAWNZERA (AUTOINJECTOR) IONIS PHARMACEUTICALS INC

    SUBCUTANEOUS FDA: approved

  19. dopamine

    NMPA: clinical trials

  20. dopamine hydrochloride

    NEOATRICON Regeneron Ireland Designated Activity Company (DAC)

    INJECTION FDA: approved Β· EMA: approved

    C01CA04
  21. doravirine

    DELSTRIGO

    ORAL FDA: approved Β· EMA: approved

    J05AG06
  22. dordaviprone hydrochloride

    MODEYSO

    ORAL FDA: approved

  23. doripenem

    DORIBAX

    INTRAVENOUS FDA: approved Β· EMA: withdrawn

    J01DH04
  24. dornase alfa

    PULMOZYME Hoffmann-La Roche

    FDA: approved Β· TGA: approved

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,797 pharmaceutical active ingredients and their marketed profiles β€” INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page β€” it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.

Data attribution and licensing: Data sources